Age and frailty in COVID-19 vaccine development.

Andrew, Melissa K; McElhaney, Janet E

Andrew, Melissa K; McElhaney, Janet E.

Andrew MK; Department of Medicine (Geriatrics) and Canadian Center for Vaccinology, Dalhousie University, Halifax, B3H 2E1, NS, Canada. Electronic address: mandrew@dal.ca.
McElhaney JE; Health Sciences North Research Institute, Sudbury, ON, Canada.

Lancet ; 396(10267): 1942-1944, 2021 12 19.

Article in English | MEDLINE | ID: covidwho-1019587

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674981
https://dx.doi.org/10.1016/S0140-6736(20)32481-8

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Lancet Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674981
https://dx.doi.org/10.1016/S0140-6736(20)32481-8

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Topics: Vaccines Language: English Journal: Lancet Year: 2021 Document Type: Article